Medication Assistance Resources

When COVID-19 began to impact our daily lives, many patients lost jobs and insurance coverage. That’s when these pharmaceutical companies stepped up to offer financial assistance programs for certain medications to help patients get the help they need. Search your condition below to explore the directory and find links to more information about each of these programs.

Is your company offering COVID-19 related assistance programs? Let our editor know by clicking here.

DIRECTORY LISTING:

LogoConditionCompanyDescriptionLink
LupusGSKThis GSK program for lupus medication provides patient assistance programs for patients who do not have insurance, or whose insurance does not cover the medication.More Info >>
AsthmaGSKThis GSK program for asthma medication provides patient assistance programs for patients who do not have insurance, or whose insurance does not cover the medication.More Info >>
Ovarian CancerGSKThis GSK program for ovarian cancer treatment provides patient assistance programs for patients who do not have insurance, or whose insurance does not cover the medication.More Info >>
Metastatic Urothelial CarcinomaJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
ADHDJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
NarcolepsyJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Multiple MyelomaJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
HIVJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Interstitial Cystitis Janssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
 OsteoarthritisJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Prostate CancerJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Tourette SyndromeJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
CancerJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Schizophrenia Janssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Diabetes (Type 2)Janssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
AnemiaJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Rheumatoid ArthritisJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Psoriatic ArthritisJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Ankylosing SpondylitisJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Crohn’s DiseaseJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Plaque PsoriasisJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Ulcerative ColitisJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
TuberculosisJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
Fungal InfectionsJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
DepressionJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
StrokeJanssen/ Johnson & Johnson JJPAF will assist eligible patients who have recently lost their jobs and their insurance coverage, enrolled patients with eligibility end dates through June 30, 2020 were extended 90 days, remains fully operational, including accepting and processing new applications.More Info >>
TelehealthBiogenBiogen has partnered with WakeMed to offer free telehealth appointments and hygiene products to the homeless impacted by COVID-19.More Info >>
Multiple Sclerosis BiogenFor patients with relapsing MS, Biogen offers care coordinators and nurse educators, live events and webinars and insurance and financial support.More Info >>
AcromegalyIpsenIpsen’s Ipsen Cares program can help with medication co-pays.More Info >>
Colon CancerIpsenIpsen’s Ipsen Cares program can help with medication co-pays.More Info >>
Rectal CancerIpsenIpsen’s Ipsen Cares program can help with medication co-pays.More Info >>
Severe Primary IGFDIpsenIpsen’s Ipsen Cares program can help with medication co-pays.More Info >>
MigrainesIpsenIpsen’s Ipsen Cares program can help with medication co-pays.More Info >>
Ovarian CancerBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
Breast CancerBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
StrokeBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
Multiple MyelomaBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
LeukemiaBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
MyelofibrosisBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
LymphomaBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
Kidney TransplantBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
CancerBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
Rheumatoid Arthritis,Bristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
Beta ThalassemiaBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
Myelodysplastic Syndrome Bristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
MelanomaBristol Myers SquibbBMS’s COVID-19 responses efforts include patient assistance with immediate access for patients who have lost their employment and health insurance, a simple, single point of entry, streamlined enrollment process, vouchers to assist with continuity of care for several self-administered BMS medicines, for eligible patients
More Info >>
DiabetesEli LillyEli Lilly provides insulin access and answers affordability questions, through their Lilly Diabetes Solution Center.More Info >>
CancerEli LillyEli Lilly provides a review of financial-assistance options, including savings card programs and independent patient-assistance foundations
More Info >>
Acute Hepatic Porphyria AlnylamAlnylam Assist® will provide a personalized care consultant to help with financial assistance for Alnylam medication.More Info >>
 Hereditary Transthyretin-Mediated AmyloidosisAlnylamAlnylam Assist® will provide a personalized care consultant to help with financial assistance for Alnylam medication.More Info >>
PainAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
AsthmaAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
GlaucomaAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
HypothyroidismAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Urinary Tract InfectionsAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
High Blood PressureAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Ulcerative ColitisAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
UlcersAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
GlaucomaAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
MenopauseAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
InfectionsAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Ulcerative ColitisAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
DepressionAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Overactive BladderAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
AnemiaAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Birth ControlAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
ConstipationAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
GlaucomaAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Urinary Track InfectionsAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Alzheimer’sAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
 Alzheimer’sAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
InflammationAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Anal FissuresAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Organ RejectionAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Bipolar DisorderAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
FibromyalgiaAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
EPIAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
SchizophreniaAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
DepressionAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
IBS-DAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
MigraineAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
Prostate CancerAllerganAllergan offers patient assistance programs for those impacted by financial difficulties due to COVID-19.More Info >>
AsthmaAstrazenecaAstraZeneca has programs that can help with financial assistance for certain medications for patients impacted by COVID-19.More Info >>
DiabetesNovo NordiskPeople with diabetes facing financial difficulties as a result of the COVID-19 pandemic can now access a free 90-day supply of insulin under Novo Nordisk Inc.’s newly enhanced Patient Assistance Program (PAP). If you’re experiencing job loss, termination of healthcare benefits, or COBRA extension due to the pandemic, you may be eligible.More Info >>
Plaque PsoriasisNovartisNovartis has a patient assistance foundation that provides free Novartis medicines to qualified individuals who experience financial hardship and who have no prescription drug coverage. More Info >>
Psoriatic ArthritisNovartisNovartis has a patient assistance foundation that provides free Novartis medicines to qualified individuals who experience financial hardship and who have no prescription drug coverage. More Info >>
Ankylosing SpondylitisNovartisNovartis has a patient assistance foundation that provides free Novartis medicines to qualified individuals who experience financial hardship and who have no prescription drug coverage. More Info >>